Dillon & Associates Inc. Has $12.96 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Dillon & Associates Inc. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% in the fourth quarter, HoldingsChannel reports. The firm owned 24,823 shares of the medical equipment provider’s stock after acquiring an additional 549 shares during the period. Intuitive Surgical makes up 1.8% of Dillon & Associates Inc.’s portfolio, making the stock its 16th biggest position. Dillon & Associates Inc.’s holdings in Intuitive Surgical were worth $12,958,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Howard Capital Management Group LLC boosted its position in Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after buying an additional 92 shares during the last quarter. Principal Financial Group Inc. boosted its position in Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after buying an additional 9,194 shares during the last quarter. Quest Partners LLC bought a new position in Intuitive Surgical in the 3rd quarter valued at $173,000. Stonebrook Private Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at $225,000. Finally, Nicolet Advisory Services LLC boosted its position in shares of Intuitive Surgical by 7.3% in the 3rd quarter. Nicolet Advisory Services LLC now owns 1,024 shares of the medical equipment provider’s stock worth $491,000 after purchasing an additional 70 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

ISRG opened at $492.49 on Monday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $175.41 billion, a PE ratio of 76.83, a PEG ratio of 5.85 and a beta of 1.43. The business’s 50-day simple moving average is $562.24 and its 200 day simple moving average is $532.03.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of analyst reports. Erste Group Bank cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Evercore ISI lifted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Finally, Truist Financial decreased their target price on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a research note on Monday, March 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $611.86.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.